1 completed, 1 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow All Malignancies: new trials by email Literature Review of All Malignancies trials Research Report on All Malignancies
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels Tazemetostat, Itraconazole, Rifampin - All Malignancies, Advanced Malignancies | Phase 1 | Completed | Epizyme, Inc. | 42 | 2020-04-23 | 2025-02-19 |
| Pharmacogenetic Determinants Of Treatment Response In Children All Malignancies, Children Being Treated for Catastrophic Illness | Recruiting | St. Jude Children's Research Hospital | 8800 | 1998-08-17 | 2026-04-29 |
Hematologic Neoplasms (1) · Lymphoma, Follicular (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Non-Hodgkin (1) · Mesothelioma (1) · Rhabdoid Tumor (1) · Sarcoma (1) · Sarcoma, Synovial (1)
Adenoma (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoma (1) · Lymphoma, B-Cell (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Complex and Mixed (1) · Neoplasms, Connective Tissue (1) · Neoplasms, Connective and Soft Tissue (1)
Itraconazole (1) · Rifampin (1) · tazemetostat (1)
Epizyme, Inc. (1) · St. Jude Children's Research Hospital (1)
United States (2) · Spain (1)
Jun J Yang, Ph. D. (1) · Kristine Crews, PharmD, MSCI (1)
P50GM115279 (1), R01CA036401 (1), R01CA264837 (1), R01GM118578 (1), R35GM141947 (1), R37CA036401 (1)